As of December 2025 Immunome has a market cap of A$3.57 Billion. This makes Immunome the world's 4385th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Dec 18th, 2025 the market cap of Immunome was reported to be: